Imagion Biosystems Ltd (ASX:IBX) Share Price

Company Profile

Business description
Imagion Biosystems Ltd operates in the field of non-invasive detection of specific solid tumor cancers by use of magnetic nanoparticles. Its principal continuing activities consisted of Nanotechnology; Biotechnology; Cancer Diagnostics; and Medical Imaging using Magnetic Resonance and Superparamagnetic Relaxometry. The company only operating segment - Research and Development. Its principal business activities consist of nanotechnology, biotechnology, cancer diagnostics, and medical imaging using Superparamagnetic Relaxometry. In addition, the company is engaged in the research and development of its clinical phase lead product which is intended for the detection and staging of metastatic HER2 breast cancer.
Contact
96-100 Albert Road
Level 4
South MelbourneVIC3205
AUS
T: +61 396927222
https://www.imagionbiosystems.com
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees

Recommended

The magnitude of growth at Broadcom continues to astound us.

William Kerwin, CFA | 10 September 2025

The banking major needs to prevent key product offerings from falling further behind the competition.

Nathan Zaia | 10 September 2025

A great fiscal 2025 but investors are ahead of themselves.

Mark Taylor | 08 September 2025

Index	Last price	Change	% Change
All Ordinaries	9,095.20	28.80	0.32%
CAC 40	7,761.32	11.93	0.15%
DAX 40	23,632.95	85.50	-0.36%
Dow JONES (US)	45,463.19	248.15	-0.54%
FTSE 100	9,225.39	17.14	-0.19%
HKSE	26,200.26	262.13	1.01%
NASDAQ	21,868.94	10.55	-0.05%
Nikkei 225	43,837.67	378.38	0.87%
NZX 50 Index	13,276.24	22.51	0.17%
S&P 500	6,527.90	15.29	0.23%
S&P/ASX 200	8,830.40	40.00	0.46%
SSE Composite Index	3,812.22	4.93	0.13%